Compare Novartis with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TTK HEALTHCARE - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS TTK HEALTHCARE NOVARTIS/
TTK HEALTHCARE
 
P/E (TTM) x 1,929.1 19.8 9,732.7% View Chart
P/BV x 25.6 1.3 1,927.9% View Chart
Dividend Yield % 1.7 1.2 148.3%  

Financials

 NOVARTIS   TTK HEALTHCARE
EQUITY SHARE DATA
    NOVARTIS
Mar-19
TTK HEALTHCARE
Mar-19
NOVARTIS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs9801,215 80.7%   
Low Rs600610 98.4%   
Sales per share (Unadj.) Rs198.7444.4 44.7%  
Earnings per share (Unadj.) Rs21.017.2 121.6%  
Cash flow per share (Unadj.) Rs22.327.6 80.6%  
Dividends per share (Unadj.) Rs10.005.00 200.0%  
Dividend yield (eoy) %1.30.5 231.0%  
Book value per share (Unadj.) Rs307.5177.9 172.8%  
Shares outstanding (eoy) m24.6914.13 174.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.02.1 193.6%   
Avg P/E ratio x37.752.9 71.2%  
P/CF ratio (eoy) x35.533.0 107.5%  
Price / Book Value ratio x2.65.1 50.1%  
Dividend payout %47.729.0 164.5%   
Avg Mkt Cap Rs m19,50812,894 151.3%   
No. of employees `0000.62.3 25.1%   
Total wages/salary Rs m1,1711,307 89.6%   
Avg. sales/employee Rs Th8,445.42,715.7 311.0%   
Avg. wages/employee Rs Th2,015.7565.3 356.6%   
Avg. net profit/employee Rs Th891.0105.4 845.3%   
INCOME DATA
Net Sales Rs m4,9076,279 78.1%  
Other income Rs m78378 1,009.8%   
Total revenues Rs m5,6896,356 89.5%   
Gross profit Rs m123496 24.8%  
Depreciation Rs m32147 21.7%   
Interest Rs m1634 47.0%   
Profit before tax Rs m858393 218.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m340149 228.3%   
Profit after tax Rs m518244 212.4%  
Gross profit margin %2.57.9 31.7%  
Effective tax rate %39.637.9 104.5%   
Net profit margin %10.63.9 271.8%  
BALANCE SHEET DATA
Current assets Rs m8,0552,717 296.4%   
Current liabilities Rs m1,8501,571 117.8%   
Net working cap to sales %126.418.3 692.5%  
Current ratio x4.41.7 251.7%  
Inventory Days Days4532 140.0%  
Debtors Days Days3447 72.7%  
Net fixed assets Rs m150991 15.1%   
Share capital Rs m123141 87.3%   
"Free" reserves Rs m7,4692,373 314.7%   
Net worth Rs m7,5922,514 301.9%   
Long term debt Rs m03 0.0%   
Total assets Rs m9,8244,158 236.3%  
Interest coverage x54.912.6 435.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.51.5 33.1%   
Return on assets %5.46.7 81.4%  
Return on equity %6.89.7 70.4%  
Return on capital %11.516.9 67.9%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m58225 25.6%   
Fx outflow Rs m1,32671 1,865.1%   
Net fx Rs m-1,269154 -823.3%   
CASH FLOW
From Operations Rs m-1,943173 -1,122.4%  
From Investments Rs m2,74297 2,841.8%  
From Financial Activity Rs m-298-307 97.0%  
Net Cashflow Rs m501-38 -1,329.7%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 3.7 54.1%  
FIIs % 1.6 5.2 30.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 25.8 83.3%  
Shareholders   41,647 12,723 327.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  GSK PHARMA  DR. DATSONS LABS  

Compare NOVARTIS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 661 Points; Banking and Finance Stocks Witness Huge Selling(Closing)

Indian share markets fell sharply today, led by weak Asian equities as worries of new lockdowns to stem surging coronavirus cases kept investors cautious worldwide.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

These 3 Recent Events Will Impact the Price of Gold(Fast Profits Daily)

Jul 1, 2020

Recent developments in the bullion market may put some short term pressure on gold prices.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jul 14, 2020 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - LUPIN COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS